NCT06722326 (HYDRAPPET) is a NA clinical trial of Dietary Supplement: Hydrogen-rich water in Obesity, sponsored by University of Novi Sad, Faculty of Sport and Physical Education.

Who is sponsoring NCT06722326?

NCT06722326 is sponsored by University of Novi Sad, Faculty of Sport and Physical Education.

What drugs are being tested in NCT06722326?

Interventions in NCT06722326: Dietary Supplement: Hydrogen-rich water, Dietary Supplement: Control water.

Is NCT06722326 still recruiting?

NCT06722326 is currently completed. Last updated 20 January 2025.

Last reviewed 2025-01-20 · How we verify

NCT06722326: HYDRAPPET

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Hydrogen-rich Water and Appetite in Obesity

Completed NA Last updated 20 January 2025

What this trial tests

NA trial testing Dietary Supplement: Hydrogen-rich water in Obesity in 36 participants. Completed in 30 December 2024.

Timeline

15 May 2024

Primary endpoint
30 December 2024

30 December 2024

Quick facts

Lead sponsor	University of Novi Sad, Faculty of Sport and Physical Education
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	supportive care
Enrollment	36
Start date	15 May 2024
Primary completion	30 December 2024
Estimated completion	30 December 2024
Sites	1 location across Serbia

Drugs / interventions tested

Dietary Supplement: Hydrogen-rich water
Dietary Supplement: Control water

Conditions studied

Obesity — all drugs for Obesity →

Sponsor

University of Novi Sad, Faculty of Sport and Physical Education

Who can join

Adults 18 to 65, any sex, with Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The main goal of this study is to investigate how dihydrogen supplementation impacts body composition, appetite, quality of life specific to obesity, and levels of the hormone GLP-1 in men and women with obesity. This randomized controlled trial aims to explore whether dihydrogen can improve these health indicators.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

Molecular Hydrogen Therapy: Mechanisms, Delivery Methods, Preventive, and Therapeutic Application.
Jin J, Yue L, Du M, Geng F, et al · · 2025 · cited 16× · PMID 40297245 · DOI 10.1002/mco2.70194
The Effects of 8-Week Hydrogen-Rich Water Consumption on Appetite, Body Composition, Sleep Quality, and Circulating Glucagon-like Peptide-1 in Obese Men and Women (HYDRAPPET): A Randomized Controlled Trial.
Todorovic N, Baltic S, Nedeljkovic D, Kuzmanovic J, et al · · 2025 · PMID 40731927 · DOI 10.3390/medicina61071299
The Effects of 8-Week Hydrogen-Rich Water Consumption on Appetite, Body Composition, Sleep Quality and Circulating Glucagon-Like Peptide-1 in Obese Men and Women (HYDRAPPET): A Randomized Controlled Trial
Todorovic N, Baltic S, Nedeljkovic D, Kuzmanović J, et al · · 2025 · DOI 10.20944/preprints202505.1491.v1

Verify or expand the search:

Other recruiting trials for Obesity

Currently open trials in the same condition.

NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting

Other University of Novi Sad, Faculty of Sport and Physical Education trials

Trials by the same sponsor.

NCT06859879 — A Combined Supplementation of Rosemary and Daylily for Enhancing Sleep Quality in Middle-Aged Adults · NA · completed
NCT06968715 — Hydrogen-Rich Water and Metabolic Health in Adults: A 12-Week Randomized Trial · NA · completed
NCT06788015 — Hydrogen-Infused Water for Endurance Performance, Body Hydration Biomarkers, and Health-Related Quality of Life · NA · completed
NCT06660004 — Creatine HCl and Creatine Ethyl Ester Supplementation in Perimenopausal and Menopausal Women · NA · completed
NCT06371651 — Creatine and GAA for Brain Oxygenation · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06722326 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Novi Sad, Faculty of Sport and Physical Education
Last refreshed: 20 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06722326.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing